loader2
Partner With Us NRI

Advanced Enzyme Technologies Ltd share Price Today

Company details

380.00
396.40
265.60
425.15
6M Return 19.61%
1Y Return 42.58%
Mkt Cap.(Cr) 4,403.63
Volume 1,43,216
Div Yield 0.25%
OI
-
OI Chg %
-
Volume 1,43,216
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Biotechnology company Advanced Enzyme Technologies announced Q1FY24 results:

  • Revenue from operations on a consolidated basis increased to Rs 1,473 million in Q1FY24 from Rs 1,211 million in Q1FY23, a growth of 22%.
  • Consolidated EBITDA during Q1FY24 stands at Rs 440 million as compared to Rs 309 million during Q1FY23, an increase of 42%.
  • Profit before tax stands at Rs 414 million during Q1FY24 as against Rs 237 million in Q1FY23, an increase of 75%.
  • Profit after tax grew by 67% and stands at Rs 294 million during Q1FY24 as compared to Rs 176 million during Q1FY23.
  • EBITDA margin stands at 30%, PBT margin stands at 28% and PAT margin stands at 20% during Q1FY24.
  • Financial costs stood at Rs 7 million during Q1FY24 as against Rs 6 million in Q1FY23.
  • Depreciation and Amortization charges for Q1FY24 remain unchanged at Rs 86 million as compared to Q1FY23.
  • Earnings Per Share during Q1FY24 stands at Rs 2.58 as compared to Rs 1.60 in Q1FY23.

 

 

Result PDF

View Other Company Results

Advanced Enzyme Technologies Ltd shares SWOT Analysis

Strengths (10)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Companies with rising net profit margins - quarterly as well as TTM basis

Weakness (5)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (3)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income
Discover More

Resistance and support

R1 400.1
R2 406.5
R3 416.5
Pivot

390.07

S1 383.7
S2 373.7
S3 367.3
EMA SMA
383.8
377.0
369.3
351.6
381.6
372.6
376.7
350.9
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-12-06 357.73 723134 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-12-06 358.11 723134 NSE
ADVANCED VITAL ENZYMES PRIVATE LIMITED Bulk Sell 2023-12-06 359.25 618105 NSE
Discover More
Name Category Shares
Kishor Laxminarayan Rathi PROMOTER 1.31%
Madhusudan Kabra PROMOTER 0.64%
Vasant Rathi PROMOTER 33.14%
Rasika Vasant Rathi PROMOTER 2.38%
Reshma Namita Rathi PROMOTER 2.37%
Rachana Vasant Rathi PROMOTER 2.36%
Prabhavati Vasant Rathi PROMOTER 0.82%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Advanced Enzyme Technologies Ltd Stocks COMPARISON

Financials( ₹ in Cr) Advanced Enzyme Technologies Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 393.80 1,506.55 1,339.55 3,793.50 982.15
% Change 2.91 0.80 -1.42 0.09 1.44
Mcap ₹ Cr 4,403.63 3,61,471.81 1,08,150.85 1,00,705.67 98,827.27
Revenue TTM ₹ Cr 540.64 43,885.68 22,753.12 7,767.51 17,237.40
Net Profit TTM ₹ Cr 103.87 8,560.84 2,835.49 1,823.38 1,997.30
PE TTM 31.46 38.52 25.40 72.78 29.65
1 Year Return 42.58 57.35 42.63 12.13 87.09
ROCE 12.02 16.79 17.79 19.30 16.25
ROE 8.94 16.46 12.82 14.89 14.05
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,235.07 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 40,292.52 -39,101.37
LAST 3M 97,195.39 -16,897.62
LAST 6M 1,59,485.99 61,690.63
LAST 12M 2,49,857.63 1,46,087.29
Board Meeting for Today

May 11, 2024 l Board Meetings for Today

Board of Advanced Enzyme Techs. recommends Final Dividend

May 11, 2024 l BSE Announcement

NSE Board Meetings Forthcomming

May 11, 2024 l NSE Board Meetings Forthcomming

DISCOVER MORE
Date Action Type Ratio
May 17, 2024 Dividend 200
Aug 04, 2023 Dividend 50
May 19, 2023 Dividend 200
DISCOVER MORE

Advanced Enzyme Technologies Ltd Information

Stock PE (TTM)
31.46
Promoter Holding
43.49%
Book Value
111.6291
ROCE
12.02%
ROE
8.94%
Registered Address

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Tel : 91-22-41703200
Email : sanjay:advancedenzymes.com; info:advancedenzymes.c
Website : http://www.advancedenzymes.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
NSE Code : ADVENZYMES
Book Closure Date (Month) :
BSE Group : B
ISIN : INE837H01020

FAQ’s on Advanced Enzyme Technologies Ltd Shares

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 10, 2024 03:44 PM the closing price of Advanced Enzyme Technologies Ltd was Rs.393.80.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 10, 2024 03:44 PM, the market cap of Advanced Enzyme Technologies Ltd stood at Rs. 4,403.63.

The latest PE ratio of Advanced Enzyme Technologies Ltd as of May 10, 2024 03:44 PM is 31.46

The latest PB ratio of Advanced Enzyme Technologies Ltd as of May 10, 2024 03:44 PM is 0.28

The 52-week high of Advanced Enzyme Technologies Ltd share price is Rs. 425.15 while the 52-week low is Rs. 265.60

According to analyst recommendations, Advanced Enzyme Technologies Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account